Background The strategy of treating rheumatoid arthritis (RA) to target involves the interaction between doctor and patient. The successful achievement of the goal is possible only if the patient informed about the treatment target and the strategy planned to reach this target under the supervision of the rheumatologist
Objectives To evaluate the patient’s attitude to the possibility of treating RA to target, to identify possible difficulties in understanding the strategy T2T.
Methods The study interviewed 30 patients with a diagnosis of RA who visited rheumatologist in Republican Clinical Hospital (Kazan, Russian Federation). We used our developed a questionnaire, which includes 51 questions.
Results Were investigated 30 patients: 27 women (91%) and 3 men (9%). The average age was 46,6 ± 3,6 years. DMARDs received 90% of patients: 6.7% (2 people) - are taking sulfasalazine, 76.7% (23 people) - methotrexate, 3.3% (1 person) - leflunomide, 3.3% (1 person) - azathioprine. Of these, 46% of patients receiving DMARDs expect prevention of structural damage, normalisation of function, 19% expect a full recovery, 20% expect a more effective pain relief, and 19% just follow doctor’s orders. 10% of patients believe that perhaps the cure of RA, 80% - no, while 10% did not know. Moreover, all patients know that they can expect in the absence of treatment (immobility, disability). All patients said that the doctor explained the tactics of treatment of their disease, but 15% of it was incomprehensible. Perhaps this can be explained by the small amount of time the doctor gave an interview with the patient - in an average of 5 to 10 minutes. All of the patients indicated that they could ask questions of your doctor and get all the answers, however, 30% identified that this information is not clear. 100% of patients reported that the explanations in the illustrations would be comfortable. Some of the patients (42.4%) scares need to monitor the disease, mainly due to the strict requirements of lifelong medication (36.3%) and damage to other organs - the liver (18%). None of the patients interviewed had never attended school for RA patients, and 80% said the need for such activities and expressed their desire to participate in educational programs for patients with RA. 77% of patients with RA were talking with the other patients, 85% of them point to a positive experience.
Conclusions Despite the fact that the majority of patients (90%) were taking DMARDs, some of them are not sufficiently informed about the aims and objectives of the treatment of RA, does not understand the explanation the doctor. To improve the quality of «doctor-patient» interaction is expedient further information programs for patients with illustrative material
Disclosure of Interest None Declared